Results 21 to 30 of about 2,227,737 (406)

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

European Heart Journal, 2023
Aims Although body mass index (BMI) is the most commonly used anthropometric measure, newer indices such as the waist-to-height ratio, better reflect the location and amount of ectopic fat, as well as the weight of the skeleton, and may be more useful ...
J. Butt, M. Petrie, P. Jhund, N. Sattar, Akshay S. Desai, L. Køber, J. Rouleau, K. Swedberg, M. Zile, S. Solomon, M. Packer, J. McMurray   +11 more
semanticscholar   +1 more source

Updates in pharmacotherapy of heart failure with reduced ejection fraction [PDF]

Annals of Translational Medicine, 2021
Heart failure is a common entity encountered in healthcare with a vast socioeconomic impact. Recent advances in pharmacotherapy have led to the development of novel therapies with mortality benefits, improvement in heart failure symptoms and hospitalizations.
Haider Alkhateeb, Tariq Siddiqui, Clifton Espinoza   +2 more
openaire   +2 more sources

Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]

, 2017
OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M, Cleland, John G.F., Cotter, Gad, Davison, Beth, Dittrich, Howard C, Givertz, Michael M, Hillege, Hans L, Khan, Mohsin A F, Mentz, Robert J, Metra, Marco, O'Connor, Christopher M, Ponikowski, Piotr, Teerlink, John R, Tromp, Jasper, van der Meer, Peter, Van Veldhuisen, Dirk J, Voors, Adriaan A.   +16 more
core   +16 more sources

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort

ESC Heart Failure, 2022
Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu   +15 more
doaj   +1 more source

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction

Biomolecules, 2022
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro, Renza Spelat, Camilla Valente, Paolo Contessotto   +3 more
doaj   +1 more source

Physicians' adherence to guideline‐recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey [PDF]

European Journal of Heart Failure, 2016
Michel Komajda, Stefan D. Anker, Martín Cowie, Gerasimos Filippatos, Bastian Mengelle, Piotr Ponikowski, Luigi Tavazzi   +6 more
openalex   +2 more sources

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

European Heart Journal, 2022
Aims To investigate the impact of patiromer on the serum potassium level and its ability to enable specified target doses of renin–angiotensin–aldosterone system inhibitor (RAASi) use in patients with heart failure and reduced ejection fraction (HFrEF ...
J. Butler, S. Anker, L. Lund, A. Coats, G. Filippatos, T. Siddiqi, T. Friede, V. Fabien, M. Kosiborod, M. Metra, I. Piña, F. Pinto, P. Rossignol, P. van der Meer, Cecilia Bahit, J. Bělohlávek, M. Böhm, J. Brugts, J. Cleland, J. Ezekowitz, A. Bayés‐Genís, I. Gotsman, A. Goudev, I. Khintibidze, J. Lindenfeld, R. Mentz, B. Merkely, Eliodoro Castro Montes, W. Mullens, J. Nicolau, A. Parkhomenko, P. Ponikowski, P. Seferovic, M. Senni, E. Shlyakhto, A. Cohen-Solal, P. Szecsödy, K. Jensen, F. Dorigotti, M. Weir, B. Pitt   +40 more
semanticscholar   +1 more source

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

Cells, 2022
Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF.
Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Eric Stöhr, Alexander E. Berezin   +4 more
doaj   +1 more source

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

KIDNEYS, 2021
No ...
No Authors
semanticscholar   +1 more source

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source